Skip to main content
. 2021 Jul 26;14(15):4149. doi: 10.3390/ma14154149

Figure 4.

Figure 4

Anti-inflammatory and angiogenic effects on the scaffolds using hBMSCs. Gene expressions of hBMSCs onto the scaffolds related to (A) anti-inflammation: IL-6 and IL-1β, and (B) angiogenesis: VEGF and MMP2 at 7 and 21 days. The differences were considered significant when ns = not significant (p ≥ 0.05), * p < 0.05, ** p < 0.01, *** p < 0.001, and # p < 0.0001 (n ≥ 3).